chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical office manager concerning a 58 year old female with type 2 diabetes mellitus, hypothyroidism, goitre, alopecia, hypertension, allergy to aspirin and penicillin allergy who on 12-OCT-2007 was vaccinated in the right arm with the first dose of PNEUMOVAX 23 (0.5 ml) (lot # 655766/0038U).  Concomitant vaccination included influenza virus vaccine (unspecified) in the left arm.  On 13-OCT-2007 the patient developed swelling underneath her armpit and redness on the injection site on the right arm.  It was reported that the patient did not have any reaction on the left arm where the influenza virus vaccine (unspecified) was administered.  Unspecified medical attention was sought.  At the time of this report, the patient was recovering.  Additional information has been requested.
Developed maculopapular Rash on forearms, along with paresthesias of the hands, bilaterally, approximately 8 hours after receiving first dose of Pfizer-BioNtech vaccine.
Patient had fever and febrile seizures, was admitted to hospital. Continues to have seizures and has had 2 other admissions as a result. From discharge summary information of eyes twitching, tonic, clonic seizures, increased somnolance. msv Medical records state questional encephalopathy, decreased appetite, decreased hearing. msv
nausea-pale, very little sleep since shot; fever 104 broke today now 101, chills, dizzy, weak; lt arm welted, inflammed, painful;
Pt was seen on 1/26/12 for an acute illness unrelated to vaccine reaction and it was noticed there was still a palpable lump on his anterior left thigh where he received the vaccines. It does not seem to bother him and is getting smaller over time.
12/11/2023 diagnosed with Metastatic Carcinoma. I recently had a Cyst removed from my back it was sent to Pathology and it was positive for Carcinoma I am currently in Chemotherapy indefinitely. They found 4 spots in my back, sternum and breast.
Headache, Myalgia, Fever & NauseaVomting Narrative
This is a spontaneous report from a contactable consumer (father). A 12-year-old male patient of unknown ethnicity received the first dose of TRUMENBA, lot number J296203 at 0.5 ml single dose on 16JUN2015. Medical history and concomitant medications were not reported. Approximately 12 hours from receiving the injection, on 16JUN2015, the patient developed a temperature of 37.6, fatigue, nausea. The patient also got sick overnight (16JUN2015). Temperature returned to normal with ibuprofen, then on 17JUN2015, the patient vomited and temperature reached highest point of 38.7C. Outcome was unknown. Follow-up attempts completed. No further information expected.
pt was exposed to sibling who recv vax 30SEP97 & on 22OCT97 pt devel a case of chickenpox;
Pain; Numbness in the hand, feet, legs, and back; This is a spontaneous report received from a contactable male consumer (patient).  A 58-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 23Apr2021, at the age of 58 years old, as 2nd single dose, for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included verapamil. Historical vaccine included 1st dose of BNT162b, via an unspecified route of administration, administered in the left arm, on 02Apr2021 at 10:00 AM (Lot Number: EN6200), at the age of 58 years old. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had never been diagnosed with COVID-19. The patient stated having been experiencing numbness in the hand, feet, legs, and back since 03May2021 at 03:30 PM. Due to the events, the patient had to schedule an appointment with a neurologist on 13May2021 and a follow-up meeting on 14Jun2021 with EMG performed on 14Jun2021 (unknown results). He was told that BNT162b2 was possibly a contributor to his condition at the time of the reporting. The patient added that at the time of the reporting he was walking with a cane since the second week of Jun2021, and was in pain. On 05Aug2021, a nasal swab was done which resulted negative. No treatment was needed for the event. The patient had not recovered from the events at the time of the reporting. According to the patient, the events were disabling.  The lot number for BNT162b2 was not provided and will be requested during follow up.
L deltoid area red, hot to touch, hard pinker area in center of 2 1/2" x 2" area. Febrile increase 101 per parent (98 in office).
Shingles; Soreness / Painful; itchy; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PAIN (Soreness / Painful), PRURITUS (itchy) and NAUSEA (Nauseous) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included LISINOPRIL and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced HERPES ZOSTER (Shingles), PAIN (Soreness / Painful), PRURITUS (itchy) and NAUSEA (Nauseous). At the time of the report, HERPES ZOSTER (Shingles), PAIN (Soreness / Painful), PRURITUS (itchy) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2021: No specific follow-up information recorded.
Cancer; This is a spontaneous report from a contactable consumer (patient's son) via a Pfizer sponsored program  Support. A 91-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (unknown age at time of vacciantion) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunisation. Event description: According to an article, Pfizer booster will be available on Sept2021 and will be upgraded to be against Delta. Patient's son wants to know more information about it. He mentioned that his father (the patient), 91-year-old and has cancer, wants to receive the booster shot. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 10-JUN-2010, the patient was inoculated with the ZOSTAVAX (lot number, dosage, and route of administration not provided), at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 01-JUN-2014, the patient was treated by a physician for a persistent and severe vesicular rash, which was diagnosed as shingles. The patient was prescribed valacyclovir, prednisone, and tramadol for management of his painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Delayed reaction few hours later of mild shortness of breath, sore throat, cough that gradually resolved over the next day. Coincided with poor air quality from wild fires.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 10-AUG-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
His arm swelled up to four times it regular size. He has a high fever. The arm was fevered too, was hard, and red to the touch.  Follow up: the involved arm was the left arm. Discharge summary states cellulitis.
Issues with poor circulation, arms and legs easily go numb with short periods of compression. No treatment pursued.
Patient recieved Prevnar 13 on 11/4/2015 and she come in on 11/30/2015 saying she had swelling of her arm and skin had blisters on it.  She said she was out of state for a month and wanted to let us know.
left radial fractures; hit left side of face - vein to eye; fell; felt terrible; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RADIUS FRACTURE (left radial fractures) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history reported.  Concomitant products included OMEPRAZOLE for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced FEELING ABNORMAL (felt terrible). On 06-Mar-2021, the patient experienced RADIUS FRACTURE (left radial fractures) (seriousness criterion hospitalization), FACE INJURY (hit left side of face - vein to eye) and FALL (fell). On 06-Mar-2021, FACE INJURY (hit left side of face - vein to eye) and FALL (fell) had resolved. On 07-Mar-2021, FEELING ABNORMAL (felt terrible) had resolved. At the time of the report, RADIUS FRACTURE (left radial fractures) outcome was unknown. Not Provided          No treatment details were reported. Was seen in ER x 2 visits , 8-Mar-2021   This case was linked to MOD-2021-137773 (Patient Link).
rash on right arm and right leg. blotchy type of rash, red, raised and itchy. still present as of 3/31/2021
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/5/2021 and 3/26/2021. Patient presented to emergency department with hypoxia and hypotension. Patient required supplemental oxygen upon arrival. Patient was transferred to a Med Cntr for admission. Patient's respiratory status continued to decline throughout hospitalization. Patient received: azithromycin, ascorbic acid, cefepime, ceftriaxone, dexamethasone, remdesivir, vancomycin, and zinc. Patient was transitioned to comfort care and expired 9/26/2021 at 2043.
heart attack; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (Private).  A 52-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (medically significant), outcome "unknown", described as "heart attack".  Clinical course: When asked question to patient. What was the name of the company or organization featured in the advertising? she reported that she was not sure exactly but she had a almost heart attack from the vaccine so she was 100 percent against it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Frontal headache, neck and shoulder pain, visual field disturbence x 5 minutes, numbness/tingling left hand, occipital headache.
Sedation, Myalgia, Arthralgia & Fever Narrative:  Other Relevant History:
It was reported that a 46 year old female pt received a Fluzone WV '99-'00 vaccination on 10/25/99. Approx. 8 hours, post vax, the pt developed a rash on her upper trunk and across back of her neck. From additional information received on 6/7/00, it was reported that the pt developed the rash on 10/29/99. The rash was located between her shoulder blades and on the posterior aspect of her neck. The pt reportedly, recovered from this experience. No additional information was provided from correspondence on 7/25/00. No further information is anticipated, this case is closed.
On 07/23, the case-patient developed cold-like symptoms (cough and runny nose), malaise, and poor feedings. Also, the mother noted the patient was fussy and irritable. On 07/25 the patient developed a fever of 103 F. On 07/27 the patient developed a non-itchy maculopapular rash on his face; by 07/28 the rash covered his entire body including the palms of his hands and soles of his feet. On 07/30, the Department of Public Health collected specimens for measles laboratory testing. Additionally, a throat swab was forwarded to CDC for RT-PCR. CDC's PCR was positive for measles -Genotype A (vaccine strain).
Pt received both Moderna Vaccines, on 1/12/2021 and on 2/9/2021. She was seen in office today due to exposure, body aches and runny nose. She tested POSITIVE for Covid-19 today. She also was given the BAM infusion today to prevent possible hospitalization.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In December 2011, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), administered by a physician, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. In July 2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
No additional AE information; Patient was vaccinated with properly stored but expired GARDASIL 9; This spontaneous report was received from a nurse refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported.  On 21-NOV-2019 the patient was vaccinated with properly stored but expired hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot # R022533, expiry date: 12-NOV-2019) (dose, frequency and route were not reported) for prophylaxis (expired product administered). No adverse effects were reported. The outcome of events were unknown, at the time of the report.
Shortly after receiving vaccine she reported tingling and numbness on left side of face and lip twitching. She saw her doctor regarding these symptoms on 9/28.
Paient was treated by healthcare providers for shingles, and other zoster-related conditions.; Patient was treated by healthcare providers for shingles, and other zoster-related conditions; Information was received from a lawyer regarding a case in litigation concerning a patient (pt) of unknown age and gender. The pt's medical history, concurrent conditions, or concomitant medication were not provided. In 2014, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided) by a helthcare professional for the long term prevention of shingles and zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation, ptwas treated by healthcare for shingles, and other zoster-related conditions. As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.  The outcome of the events was not reported. The events were reported to be related to zoster vaccine live (ZOSTAVAX).
death/died; Couldn''t even urinate, collapsed with kicking by Mess, like to trauma unit.; swelling from the waist down; collapsed with kicking by Mess, like to trauma unit; This is a spontaneous report from a non-contactable consumer. A 62-year-old male patient (Uncle) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 23Jun2021 (at the age of 62 years old) (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history included hospitalization. Patient had had multiple hospitalization. No Other Medical Conditions, not even cold, no diabetes, no cancer. The patient's concomitant medications were not reported. The patient declared death and died on 24Jun2021 from the Pfizer vaccine. He died because he was forced to get the shot to keep his job and died within 24 hour and that was in the report. He died in the trauma unit of the hospital. It was unknown if an autopsy was performed. He experienced swelling from the waist down immediately after his 2nd shot and by that evening, couldn't even urinate, collapsed with kicking by Mess, like to trauma unit and died next morning and doctor declared, It's a vaccine injury. For Height and Weight, Reporter Stated, "Probably 6 foot may be 175 (not clarify, hence not captured in tab). For Other Medications, Reporter Stated, "Not that I am aware of. They are not take any medications". The patient was hospitalized on the 23rd, that evening he admitted, 23rd June (23Jun2021). Seriousness for He died in the trauma unit of the hospital was Hospitalization, Death. The patient underwent lab tests and procedures which included lab test with unknown results on an unspecified date. The outcome of the event death/died was fatal, of the other events was unknown.   No follow-up attempts are possible; information about lot/batch cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101335055 same reporter/drug, different patient/event.;US-PFIZER INC-202101335048 same reporter/drug, different patient/event.; Reported Cause(s) of Death: death/died
flu shot they really help even though some of the side effects hit me though I don't like but good get a flu shot; Initial information received on 19-Oct-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves patient of unknown age and gender who had influenza vaccine and reported that flu shot they really help even though some of the side effects hit me though i don't like but good get a flu shot.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (formulation; strength; lot number; expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient reported that flu shot they really help even though some of the side effects hit me though i don't like but good get a flu shot (immunisation reaction) (unknown latency) following the administration of influenza vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Day 5-lymph nodes in neck/behind collar bone on injection side swelled and became sensitive. Still slightly swollen on day 17 but sensitivity had faded by day 14; day 7-2?x3? reddened area appeared at injection site; no itching or sensitivity; faded by day 11.
Patient reported her tongue felt tingly 5 minutes following the first dose.  She reported this finding at today's visit.  She said she just took a Benadryl when she got home following her first dose.  I did question if she has had anaphylaxis in the past to any meds, etc, and she said no, but reported having allergic symptoms with an antibiotic.  No other allergic history to vaccines, meds, etc.  Patient wanted to continue with second dose of vaccine today.  Vaccinated at 1615.  Patient reported tongue tingling at 1640.  25mg PO Benadryl given at 1640.  Patient left the clinic at 1700 stating that she felt ok to leave.  She had Benadryl at home and knew who to call if symptoms worsened.  Writer called the patient back on 1/26/2021 at 1100.  Patient stated that at 1900 last night (1/25/2021) she had to go to the Emergency room and received 2 doses of Epinephrine.  She then had to stay the night to be observed.  Patient stated that she was being discharged today.
left eye and left side of mouth was not working/Bell's palsy.; left ear was hurting all day; drainage in patient left ear; neck down to elbow was sore; neck down to elbow was sore/soreness on arm; neck down to elbow was sore; This is a spontaneous report from a contactable consumer. This 32-year-old female consumer  (non-pregnant) reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 13Mar2021 10:00 (Batch/Lot Number: EN6208) as single dose for covid-19 immunisation. Medical history was none. Concomitant medications included metformin and prenatal vitamin. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. About 30 mins after the shot patient neck down to elbow was sore. On 14Mar2021 the soreness on arm went away but patient neck was still sore. 14Mar2021 night there was drainage in patient left ear. On 15Mar2021 patient left ear was hurting all day. 16Mar2021 morning (07: 45 am) patient woke up with no more pain in left ear, but left eye and left side of mouth was not working. Patient went to ER and they said patient have Bell's palsy. Patient had no control of the left side of face by 18Mar2021. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient had not been tested for COVID-19. Event Bell's palsy resulted in emergency room/department or urgent care, disability or permanent damage, and patient received unspecified medications as treatment for the event.  Outcome of events pain in arm/elbow was recovered on 14Mar2021, outcome of event left ear was hurting was recovered on 16Mar2021, outcome of events Bell's palsy and neck pain was not recovered, and outcome of event drainage in patient left ear was unknown.